Jennifer Krajewski
Overview
Explore the profile of Jennifer Krajewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daw S, Cole P, Hoppe B, Hodgson D, Beishuizen A, Garnier N, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39745739
Importance: Retrieval strategies for children, adolescents, and young adults with relapsed classic Hodgkin lymphoma (cHL) aim to maintain efficacy while minimizing long-term toxic effects. Children, adolescents, and young adults with...
2.
Zinzani P, Salles G, Moskowitz A, Santoro A, Mehta A, Barr P, et al.
Blood Adv
. 2024 Mar;
8(10):2400-2404.
PMID: 38531062
No abstract available.
3.
Forlenza C, Rosenzweig J, Mauguen A, Buhtoiarov I, Cuglievan B, Dave H, et al.
Blood Adv
. 2023 Mar;
7(13):3225-3231.
PMID: 36897253
Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with ∼50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-free...
4.
McNerney K, Richards R, Aguayo-Hiraldo P, Calkoen F, Talano J, Moskop A, et al.
J Immunother Cancer
. 2023 Jan;
11(1).
PMID: 36707090
Background: Immunocompromised patients are at increased risk of SARS-CoV-2 infections. Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B-cell...
5.
Stenger E, Xiang Y, Wetzel M, Gillespie S, Chellapandian D, Shah R, et al.
Transplant Cell Ther
. 2022 Oct;
29(1):47.e1-47.e10.
PMID: 36273784
Hematopoietic cell transplantation (HCT) is an established cure for sickle cell disease (SCD) supported by long-term survival, but long-term organ function data are lacking. We sought to describe organ function...
6.
Krajewski J, Chen J, Motiani J, Baer A, Appel B, Zakrzewski J, et al.
Pediatr Transplant
. 2021 Oct;
26(2):e14179.
PMID: 34708505
Background: The SARS-CoV-2 pandemic brought challenges to all areas of medicine. In pediatric bone marrow transplant (BMT), one of the biggest challenges was determining how and when to transplant patients...
7.
Hochberg J, Zahler S, Geyer M, Chen N, Krajewski J, Harrison L, et al.
Bone Marrow Transplant
. 2018 Jun;
54(2):226-235.
PMID: 29899571
Acute leukemias in children with CR3, refractory relapse, or induction failure (IF) have a poor prognosis. Clofarabine has single agent activity in relapsed leukemia and synergy with cytarabine. We sought...
8.
Satwani P, Freedman J, Chaudhury S, Jin Z, Levinson A, Foca M, et al.
Biol Blood Marrow Transplant
. 2017 Jan;
23(4):642-647.
PMID: 28104513
Blood stream infections (BSI) caused by enteric organisms are associated with a particularly high mortality rate in allogeneic hematopoietic cell transplantation (alloHCT) recipients. We conducted a retrospective multicenter study aiming...
9.
King A, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi R, et al.
Am J Hematol
. 2015 Sep;
90(12):1093-8.
PMID: 26348869
Fifty-two children with symptomatic sickle cell disease sickle cell disease (SCD) (N = 43) or transfusion-dependent thalassemia (N = 9) received matched sibling donor marrow (46), marrow and cord product...
10.
Villanueva H, Kuril S, Krajewski J, Sedrak A
Case Rep Pediatr
. 2013 Oct;
2013:875683.
PMID: 24159402
Introduction. Sickle cell hemoglobin D disease (HbSD) is a rare variant of sickle cell disease (SCD). Incidence of pulmonary thromboembolism (PE) and deep venous thrombosis (DVT) in children with HbSD...